Wednesday, October 6, 2010

Orthotics Brisbane

Copythotics™

What is a Copythotic™?

Envisage cutting a 1 mm slice from your existing orthotics that took off only its upper most surface. Now imagine that thin layer sitting in your shoe. It is going to fit into a lot more shoes and take up a lot less room. There is a bit of empty space sitting under the arch. Once this is filled in using high tech foam material, you have yourself a Copythotic™.

There is a lot to know about Copythotics. So much in fact, they have got their own website at Orthotics Brisbane. Read on here for more general information or browse to the site directly.

The Copythotic™ foot orthotic was created in Brisbane Australia through a collaboration by the Walk Without Pain Orthotic and Podiatry Clinic group and Stephanie Cosgrove Podiatry Clinics. International interest is already building in this humble Brisbane invention.

Why did we invent the Copythotic™?

After practicing podiatrist Brisbane for more than twenty years, it became clear that “sensible but comfortable” shoes do not always triumph over the “stylish but crippling” variety. When it comes to choosing your shoes, we understand that there are many factors that are important to you.

Despite what your own podiatrist has said (and what I’ve told my clients for most of those years), the key components of a functional orthotic device that has been designed for you really will fit into your existing footwear. It just takes some refining. In using the Copythotic™ process for our patients over recent years, we have found that an orthotic shoe insert that fits most of the footwear that most women find acceptable most of the time, will provide an average of around 80% of the original orthotics potency. That makes our clients more than mostly happy! No more orthotic shoes, Brisbane!

Why might you want some Copythotics?

There are many good reasons why you might want a copy pair of orthotics. Perhaps you would like:

a big, cushioned pair for your runners so that they won’t slip around,

a really small pair for your sleeker shoes,

new orthotics to replace the ones your dog chewed up,

to never have to swap your orthotic insert from shoe to shoe again, or

a pair to leave in your duty shoes at work.

How come Copythotics are cheaper orthotics?

Copythotic orthotic devices are cheaper because 60% of the work has already been done to make your first pair. It does not seem fair that you have to pay for all that stuff to happen again ! The Copythotic™ is a unique, patented (pending) process where the model is actually your existing orthotic plate. In most cases, everything we need to know about your feet can be ‘extracted’ from that plate.

Can I get a rebate for a Copythotic?

Copythotic orthotics are custom made for you and we are podiatrists so health fund rebates do apply.

Will my orthotic be hard or soft? Soft Orthotics

Copythotic™ orthotics have several possible construction materials with nearly infinite combinations. It can be as flexible or as solid as we want to make it. It can also be easily adjusted right up to the final stage of the manufacture, allowing for a ‘fitting’ visit if required.

At Walk Without Pain ! Podiatry Clinics, we often hear patients say that, although their orthotics have solved their original problem, they don’t like wearing them. In deciding how stiff to make your Copythotic™, we would routinely consider your age, fitness, foot problems, weight, work surfaces, activities, severity of symptoms, duration of pain, choice of footwear and how you responded to your previous orthotics. We also invite your opinion. While our podiatrists can tell you volumes about feet in general – there are things about your feet that only you can tell us.

I don’t like my orthotics – why would I want to copy them?

If your existing orthotic devices are perfect, we just need them for a few minutes to model your new orthotics.

If your orthotic is not exactly right (perhaps it is too stiff, too big, too high), it takes a little bit more care, but not a lot more time. To craft a Copythotic™.If you are not happy with your existing orthotic foot supports, wherever they were made for you, an appointment with one of our podiatrists will be necessary. Just about every custom made orthotic would be suitable for reinterpretation as a Copythotic™, even if you never felt that you could wear them.

If your existing orthotics are beyond salvation, we can help you with a new pair and throw in a complementary pair of Copythotics™.

If you don’t have orthotics but think you might need some, it will be necessary to see our podiatrists for a more thorough examination.

Lastly, Copythotics are not the only kind of orthotic shoe insert that we make. Browse to our page on the various types of orthotics for some more information.

Stephanie Cosgrove.




If you found this article interesting please subscribe for updates with any reader or your email. Also be sure to check out my soon to launch membership website TheStockman.ORG, Bookmark & Share on ANY social site:Bookmark and Share

Indications: U.S. stock futures turn lower after ADP data

Stock Assault 2.0 - Artificial Intelligence Stock Market Software Alert Email Print

By Simon Kennedy and Kate Gibson, MarketWatch

NEW YORK (MarketWatch) â€" U.S. stock-market futures reversed earlier gains to tally modest losses Wednesday after ADP reported that the private sector unexpectedly shed 39,000 jobs in September.

TODAY'S TOP MARKET STORIES

S&P 500 (1 YEAR)

• Market Snapshot: U.S. stocks in focus • Today's biggest advancing, declining stocks • Sign up for free, breaking-news email alerts

Earnings Watch | Earnings, updates, warnings

THE MARKET BY SECTOR | Industries • Tech Stocks | Energy Stocks | Retail Stocks • Financials | Airline Stocks | Pharma and Biotech

EXPANDED MARKETS NEWS • Bonds | Oil news | Gold news • Currencies | Market Data | Economic Calendar • See all the latest markets video

/conga/story/misc/markets.html 84614

But the data, which come two days before the government’s monthly employment report, also included an upward revision for August.

“The markets have the reality of a sluggish economy on one hand faced up against more [quantitative easing] on the other. With this said, market participants pay much more attention to the government payrolls report, and thus Friday’s figure will be more market-moving,” wrote Peter Boockvar, equity strategist at Miller Tabak, in a note.

Up nearly 30 points before the report, futures for the Dow Jones Industrial Average /quotes/comstock/21b!f:dj\z10 (DJZ10 10,910, +46.00, +0.42%)  were lately down 3 points to 10,861, and those for the Nasdaq 100 /quotes/comstock/21m!f:nd\z10 (NDZ10 2,008, -10.50, -0.52%)  fell 4.25 points to 2,014.25.

S&P 500 futures /quotes/comstock/21m!f:sp\z10 (SPZ10 1,157, +2.10, +0.18%)  were off 1.2 points to 1,153.5.

U.S. markets rallied sharply Tuesday, as the Dow industrials jumped more than 193 points to close within striking distance of 11,000 and at its highest level since May.

European stocks wait for U.S. jobs data

European markets are looking ahead to more exciting events later in the week, although commodities and commodity stocks are bid as they might be among the beneficiaries of more quantitative easing.

Among currencies, the dollar edged lower against the Japanese yen, recently down at ¥82.99.

Crude-oil futures fell 40 cents to $82.42 a barrel, while gold continued its ascent, as the December contract briefly surpassed $1,350 an ounce.

Among companies in focus, Costco Wholesale Corp. /quotes/comstock/15*!cost/quotes/nls/cost (COST 63.70, -0.96, -1.48%)  said its fiscal fourth-quarter net income rose 16% to $432 million, or 97 cents a share, on a 7.8% increase in net sales. Analysts had expected a profit of 95 cents a share. Shares of the company slipped 2.7% in premarket trading.

Earnings season will get into full swing after Thursday’s close, when Alcoa Inc. /quotes/comstock/13*!aa/quotes/nls/aa (AA 12.45, +0.31, +2.55%)  reports its third-quarter numbers.

Earnings expectations for blue-chip companies are relatively high, so any market reaction is likely to be more violent on bad news than on good news â€" broadly the opposite of the situation with employment data, RBS analysts said.

In deal news, Johnson & Johnson /quotes/comstock/13*!jnj/quotes/nls/jnj (JNJ 62.71, -0.09, -0.15%)  said it will buy the 82% of biopharmaceutical company Crucell /quotes/comstock/15*!crxl/quotes/nls/crxl (CRXL 34.16, +0.34, +0.99%)   /quotes/comstock/24s!e:crxl (NL:CRXL 24.64, +0.09, +0.37%)  that it doesn’t already own for 1.75 billion euros ($2.42 billion).

General Electric Co. /quotes/comstock/13*!ge/quotes/nls/ge (GE 16.96, +0.45, +2.73%)  said it had a bid turned down by the U.K.’s Wellstream Holdings PLC /quotes/comstock/23s!e:wsm (UK:WSM 761.00, -19.00, -2.44%) . GE said there’s no certainty it will increase its bid, which was worth around $1.2 billion.

In international markets, Japan’s Nikkei 225 Average closed up 1.8%, while France’s CAC 40 index was recently up 0.8%. See Europe Markets

Simon Kennedy is the City correspondent for MarketWatch in London. Kate Gibson is a reporter for MarketWatch, based in New York.

Powered By iWebRSS.com

NYSE Arca Morning Update - 08:30:00 ET

NYSE Arca Morning Update for Wednesday, Oct 6, 2010 :

STOCKS TRADING ON NYSE Arca AT A PRICE 15% OR MORE AWAY FROM
THE PREVIOUS TRADE DAY'S CONSOLIDATED CLOSE PRICE (AS OF 08:30:00 ET)

Stock Tuesday's Close Current Price Pct Change Current NYSE ARCA Vol
RNO $22.65 $41.33 82.5% 2,400
EQIX $105.00 $78.08 (25.6%) 168,264


10 MOST ACTIVE STOCKS ON NYSE ARCA AS OF 08:30:00 ET

BASED ON DOLLARS TRADED: | BASED ON SHARES TRADED:
Stock $ Volume Price PctChg | Stock Share Vol Price PctChg
SPY $156379297 $115.97 ( 0.1%) | C 3,701,097 $4.16 0.4%
AAPL $16,945,770 $289.92 0.3% | SPY 1,345,953 $115.97 ( 0.1%)
C $15,398,225 $4.16 0.4% | BAC 1,074,382 $13.60 0.2%
GLD $15,367,773 $131.31 0.2% | AIB 197,428 $1.29 ( 3.7%)
BAC $14,611,801 $13.60 0.2% | F 184,857 $13.07 0.5%
EQIX $13,370,333 $78.08 (25.6%) | FAS 179,083 $22.73 ( 0.1%)
MON $7,382,476 $49.40 1.2% | FAZ 169,786 $12.49 0.1%
QQQQ $7,376,504 $49.57 ( 0.2%) | EQIX 168,264 $78.08 (25.6%)
BHP $7,004,327 $79.66 1.9% | SDS 162,417 $28.58 ( 0.0%)
SDS $4,633,846 $28.58 ( 0.0%) | MON 149,198 $49.40 1.2%


Price changes may be affected by symbol splits and dividends.

Consolidated close price is the last print (excluding prints with trade
conditions) prior to 4PM ET.

This information is also updated on our web page every morning at 8:35ET:
http://www.tradearca.com/data/volume/daily_update.asp

This material is for informational purposes only.
NYSE Euronext and its affiliates ("NYSE Arca") are not soliciting any action based upon it.
This material is not to be construed as an offer to buy or sell any security in any jurisdiction where such an offer or solicitation would be illegal.
Any opinions expressed in this material are NYSE Arca opinions only.
NYSE Arca undertakes no obligation to update any of the information contained in this material in light of new information or future events.
THIS MATERIAL IS PROVIDED BY NYSE ARCA "AS IS" AND WITHOUT WARRANTIES EXPRESS OR IMPLIED.
NYSE ARCA DISCLAIMS ALL WARRANTIES INCLUDING THE IMPLIED WARRANTIES OF MERCHANTIBILITY, TITLE, AND FITNESS FOR A PARTICULAR PURPOSE AS TO THIS MATERIAL.
IN NO EVENT SHALL NYSE ARCA BE LIABLE FOR DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER (INCLUDING BUT NOT LIMITED TO, LOST PROFITS, TRADING LOSSES AND DAMAGES THAT MAY RESULT FROM THE USE
OF THIS MATERIAL, ANY DELAY OR INTERRUPTION OF SERVICE OR OMISSIONS OR INACCURACIES IN THE MATERIAL) WITH RESPECT TO THIS MATERIAL.

Copyright [2010] by NYSE Euronext. All rights reserved. Reproduction and redistribution prohibited without prior express consent.

Subscribe to "The $t0ckman" via email

Enter your email address:

Delivered by FeedBurner